Showing results (1-10 of 223) with videos related to
Sort By:
Pageof 23
Advances in Chronic Kidney Disease|March 17, 2016
Cardiovascular Pharmacogenomics--Implications for Patients With CKDLarisa H Cavallari, Darius L MasonExpert Review of Cardiovascular Therapy|July 13, 2017
Personalizing antiplatelet prescribing using genetics for patients undergoing percutaneous coronary interventionLarisa H CavallariJournal of Pharmacy Practice|August 22, 2012
Tailoring drug therapy based on genotypeLarisa H CavallariTrends in Cardiovascular Medicine|October 6, 2014
Warfarin pharmacogeneticsJulie A Johnson, Larisa H CavallariInterventional Cardiology Clinics|September 8, 2024
Genetic Determinants of Response to P2Y<sub>12</sub> Inhibitors and Clinical ImplicationsLarisa H Cavallari, James C CoonsThe Journal of Cardiovascular Nursing|November 6, 2004
New treatment option for heart failure patients: eplerenoneMary Ross Southworth, Larisa H CavallariCurrent Opinion in Molecular Therapeutics|May 30, 2009
Warfarin pharmacogenomicsLarisa H Cavallari, Nita A LimdiPharmacological Reviews|May 21, 2013
Pharmacogenetics and cardiovascular disease--implications for personalized medicineJulie A Johnson, Larisa H CavallariInterventional Cardiology Clinics|November 26, 2016
Genetic Determinants of P2Y<sub>12</sub> Inhibitors and Clinical ImplicationsLarisa H Cavallari, Aniwaa Owusu ObengCell Reports. Medicine|April 21, 2023
Use of a multi-gene pharmacogenetic panel reduces adverse drug effectsLarisa H Cavallari, Julie A JohnsonPageof 23